Home

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

PAS-22-196

Due Date:

2023-01-05,2023-04-05,2023-09-05,2024-01-05,2024-04-05,2024-09-05,2025-01-05,2025-04-05,2025-09-05

Posted Date:

2022-06-21

Description

Recommendations and milestones for Alzheimer's disease (AD) and AD-related dementias (ADRD) research from the National Alzheimer’s Project Act and the 2015, 2018, 2019, and 2021 Alzheimer's Disease

Solicitation Link:

https://www.sbir.gov/node/2230639

Application Link:

https://grants.nih.gov/grants/guide/PA-files/PAS-22-196.html

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

PAS-22-197

Due Date:

2023-01-05,2023-04-05,2023-09-05,2024-01-05,2024-04-05,2024-09-05,2025-01-06,2025-04-07,2025-09-05

Posted Date:

2022-06-21

Description

Recommendations and milestones for Alzheimer's disease (AD) and AD-related dementias (ADRD) research from the National Alzheimer’s Project Act and, the 2015, 2018, 2019, and 2021 Alzheimer's Disease

Solicitation Link:

https://www.sbir.gov/node/2230635

Application Link:

https://grants.nih.gov/grants/guide/PA-files/PAS-22-197.html

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

PAR-23-032

Due Date:

2023-01-05,2023-04-05,2023-09-05,2024-01-05,2024-04-05,2024-09-05,2025-01-06,2025-04-04,2025-09-05

Posted Date:

2022-10-27

Description

Purpose This Funding Opportunity Announcement (FOA) encourages the translation of technology and therapeutic innovations from academic and other non-profit research sectors to the marketplace to ad

Solicitation Link:

https://www.sbir.gov/node/2265723

Application Link:

https://grants.nih.gov/grants/guide/PA-files/PAR-23-032.html

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

RFA-NS-23-006

Due Date:

2023-01-04,2023-04-04,2023-09-04,2024-01-04,2024-04-04,2024-09-04,2025-01-03,2025-04-04

Posted Date:

2022-09-15

Description

Purpose The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and

Solicitation Link:

https://www.sbir.gov/node/2249297

Application Link:

https://grants.nih.gov/grants/guide/RFA-files/RFA-NS-23-006.html

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

RFA-NS-23-007

Due Date:

2023-01-04,2023-04-04,2023-09-04,2024-01-04,2024-04-04,2024-09-04,2025-01-03,2025-04-04

Posted Date:

2022-09-15

Description

Purpose The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and

Solicitation Link:

https://www.sbir.gov/node/2249301

Application Link:

https://grants.nih.gov/grants/guide/RFA-files/RFA-NS-23-007.html

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

RFA-DA-23-021

Due Date:

2022-08-15,2023-02-14,2023-08-15,2024-02-14,2024-08-13,2025-02-14

Posted Date:

2022-03-28

Description

According to the Centers for Disease Control and Prevention (CDC), more than 100,000 deaths from overdose were reported from April 2020 to April 2021 alone. Data shows an increase in overdoses due to

Solicitation Link:

https://www.sbir.gov/node/2199561

Application Link:

https://grants.nih.gov/grants/guide/RFA-files/RFA-DA-23-021.html

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

PAR-22-103

Due Date:

2022-03-28,2022-12-05,2023-03-27,2023-12-04,2024-03-27,2024-12-04

Posted Date:

2022-01-21

Description

Background Currently, there are only three medications (four formulations) approved by the FDA for the treatment of alcohol use disorder (AUD). The need for additional medications to treat those af

Solicitation Link:

https://www.sbir.gov/node/2280855

Application Link:

https://grants.nih.gov/grants/guide/pa-files/PAR-22-103.html

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

PAR-22-102

Due Date:

2022-03-28,2022-12-05,2023-03-27,2023-12-04,2024-03-27,2024-12-04

Posted Date:

2022-01-21

Description

Background Currently, there are only three medications (four formulations) approved by the FDA for the treatment of alcohol use disorder (AUD). The need for additional medications to treat those af

Solicitation Link:

https://www.sbir.gov/node/2146317

Application Link:

https://grants.nih.gov/grants/guide/pa-files/PAR-22-102.html

Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

PAR-21-226

Due Date:

2021-09-06,2022-01-05,2022-04-05,2022-09-05,2023-01-05,2023-04-05,2023-09-05,2024-01-05,2024-04-05

Posted Date:

2021-04-30

Description

Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms

Solicitation Link:

https://www.sbir.gov/node/1972473

Application Link:

https://grants.nih.gov/grants/guide/PA-files/PAR-21-226.html

Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)

Federral Agency:

Department of Health and Human Services

Solicitation Number:

PAR-21-225

Due Date:

2021-09-05,2022-01-05,2022-04-05,2022-09-05,2023-01-05,2023-04-05,2023-09-05,2024-01-05,2024-04-05,2024-09-05

Posted Date:

2021-04-30

Description

Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms

Solicitation Link:

https://www.sbir.gov/node/1978901

Application Link:

https://grants.nih.gov/grants/guide/pa-files/PAR-21-225.html

Non-dilutive funding for R&D and STEM entrepreneurs

You need funding to build your product

Use our tools to go from reactive to proactive

Grant Search

Training

Free guide

Free grant search listings

We’re entrepreneurs also – we know how hard it is to find the time to raise the funding that you need.

Colleen Spiegel, Ph.D.

You need non-dilutive funding to develop your idea

Free Guide